CSIMarket Company Name, Ticker, Customers, else..


Zimmer Biomet Holdings Inc   (NYSE: ZBH)
Other Ticker:  
 


 

Zimmer Biomet Holdings Inc

ZBH's Financial Statements and Analysis



Zimmer Biomet Holdings Inc reported in the first quarter of 2025 net earnings per share of $0.91 an increase by 8.33 % year on year from $0.84 and decline of -24.31 % from $1.20 earned in IV. Quarter (Dec 31 2024).


first quarter of 2025
Earnings Per Share Revenues
$ 0.91 $  1,909 Mill
$+0.07     +8.33 % $+20M     +1.05 %



Zimmer Biomet Holdings Inc 's Revenue rose by 1.05 % in first quarter of 2025 (Mar 31 2025) year on year, to $1,909 million and declined by -5.64 % sequentially.


Zimmer Biomet Holdings Inc is

More on ZBH's Income Statement



Zimmer Biomet Holdings Inc 's net income of $182.600 million in the first quarter of 2025 increased by 5.67 % from net earnings of $172.800 million achieved in I. Quarter a year ago.

Sequentially net earnings fell by -23.95 % from net income of $240.100 million realized in previous quarter.

More on ZBH's Growth

Zimmer Biomet Holdings Inc Inventories
Inventories declined by -6.03 % to $2,244.20 million from I. Quarter a year ago, sequentially inventories rose by 0.4 %. ZBH's Cash flow In the first quarter of 2025 company's net cash flow was $859 million, capital expenditures grew by -67.6-30.47%, to $-47 millions compare to same quarter a year ago

More on ZBH's Cash flow Statement


Zimmer Biomet Holdings Inc payed out dividend of $0.96 per share in last 52 weeks representing 21.24 % of net earning per share in trailing twelve-month period.

During the same period Zimmer Biomet Holdings Inc earned $ 8.28 cash per share, on a free-cash flow basis 183.26 % of net earning per share.

Book value grew by 1.57 % sequentially to $62.11 per share, 21.61% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value fell to $ -5.27 per share from $ -5.26.

Company repurchased 4.32 million shares or 2.12 % in Mar 31 2025.
Interest Coverage Ratio was 5.5. Debt Coverage Ratio was 0.2.

• More on ZBH's Dividends

 Market Capitalization (Millions) 18,816
 Shares Outstanding (Millions) 200
 Total Debt (Millions $) 7,176
 Revenue (TTM) (Millions $) 7,699
 Net Income (TTM) (Millions $) 915
 Cash Flow (TTM) (Millions $) 992
 Capital Exp. (TTM) (Millions $) -336
 Dividend TTM ($) 0.96 $
 Dividend Yield TTM (%) 1.02 %
 Employees (TTM) $ 18,000




Zimmer Biomet Holdings Inc payed out dividend of $0.96 per share in the last 52 weeks representing 21.24 % of net earning per share in trailing twelve-month period.

During the same period Zimmer Biomet Holdings Inc had $ 8.28 cash flow per share, on a free-cash flow basis 183.26 % of net earning per share.

Book value grew by 1.57 % sequentially to $62.11 per share, 21.61% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value fell to $ -5.27 per share from $ -5.26.

Company repurchased 4.32 million shares or 2.12 % in Mar 31 2025.
Interest Coverage Ratio was 5.5. Debt Coverage Ratio was 0.2.

• More on ZBH's Balance Sheets

 Market Capitalization (Millions) 18,816
 Shares Outstanding (Millions) 200
 Total Debt (Millions $) 7,176
 Revenue (TTM) (Millions $) 7,699
 Net Income (TTM) (Millions $) 915
 Cash Flow (TTM) (Millions $) 992
 Capital Exp. (TTM) (Millions $) -336
 Dividend TTM ($) 0.96 $
 Dividend Yield TTM (%) 1.02 %
 Employees (TTM) $ 18,000
   


  News about Zimmer Biomet Holdings Inc Earnings

Zimmer Biomet Holdings Inc's Fiscal Third Quarter Sees Mixed Results with 16.3% Drop in Earnings per Share

Zimmer Biomet Holdings Inc Faces Mixed Performance in Fiscal Third Quarter
In the fiscal third quarter of 2023, medical equipment and supplies company Zimmer Biomet Holdings Inc (ZBH) reported different earnings results. While the company experienced a 5.019% increase in revenue to $1.75 billion compared to the previous year, its income fell by -16.3% to $0.77 per share from $0.92 per share in the prior year reporting period.
The revenue decrease of -6.205% from the previous quarter, coupled with a -23% decline in income from $1.00 per share, paints a varied picture for investors. However, Zimmer Biomet Holdings Inc remains determined to prioritize considered spending and investments, development, an...

Zimmer Biomet Holdings Inc Reports Impressive 36.99% Surge in Profit Per Share, Alongside 4.928% Revenue Boost in Q2 2023 Earnings Season

Zimmer Biomet Holdings Inc, a prominent Medical Equipment and Supplies company, has experienced some significant developments in its stock performance in recent trading days. Over the course of the last five trading days, its stock saw a decline of -5.39%. However, despite this short-term setback, the year-to-date performance stands at a positive 3.92%. Currently, Zimmer Biomet Holdings Inc's stock is trading on the NYSE at a price 6.2% higher than its 52-week average.
Examining the financial results from the quarter ending on June 30, 2023, Zimmer Biomet Holdings Inc displayed impressive figures and growth in various areas. Notably, the company's earnings per share (EPS) significantly outpaced revenue g...

Strong Eps Underlines Double Digits revenue rise at in the first quarter of 2023

Zimmer Biomet Holdings Inc's latest financial report for the first quarter of 2023 showed improvements in its Return on Equity, with the ROE standing at 3.71% compared to the previous quarter's 1.92%. Despite this, the figure remains below the company's average return on equity of 4.57%. While nine other companies in the Biotechnology and Pharmaceuticals industry had a higher ROE, Zimmer Biomet's overall ranking for the metric improved in the first quarter, moving up to 529 from 2305 in the fourth quarter of 2022.
Investors will be pleased to note that Zimmer Biomet's earnings per share soared by an impressive 1485.71% to $1.11 in t...


Date modified: 2025-05-06T07:42:26+00:00





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com